MoneyWorks4Me

Gujarat Themis Biosyn informs about analyst meet

17 Sep 2021 Evaluate

Pursuant to regulation 30(6) at the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Listing Regulations’) read with part A of Schedule III of the Listing Regulations, Gujarat Themis Biosyn has informed that the management of the Company will have a one-on-one conference call with Analysts/ investors on Friday, 17th September 2021 with Rona Asset Managers. The schedule of the meetings is subject to change. The changes may happen due to exigencies on the part of Fund/ Broking House/ Company. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company: www.gtbl.in.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..